-transparent.png){kind=logo}
The block of endplate currents (EPCs) by succinylcholine, in frog cutaneous pectoris muscles, is significantly potentiated by certain organic calcium channel antagonists, at concentrations at which the calcium channel antagonists have no effect on EPCs themselves. Succinylcholine alone blocked the current in a dose-dependent manner with an IC50 = 2.7 microM in voltage-clamped muscle fibers. The ability of succinylcholine to block endplate currents was potentiated by nicardipine (3.5- and 31-fold by 1 and 10 microM, respectively), by bepridil (4.3-fold by 1 microM), and by verapamil (7.7-fold by 10 microM). The dihydropyridine nifedipine (10 microM), did not potentiate the succinylcholine effect. Since the calcium channel antagonists do not affect endplate currents directly at these concentrations, a channel blocking or receptor antagonistic effect of these drugs is not indicated. We therefore suggest that the enhancement of block by succinylcholine may be due to the increased desensitization of the receptor. Furthermore, this enhancement of desensitization may explain the effects of these calcium channel antagonists seen in whole animal studies, where the contractures caused by acetylcholine and succinylcholine, applied systemically, are blocked.
L P Adam, and
E G Henderson
January 1992,
Journal of neural transmission. General section,
L P Adam, and
E G Henderson
December 1995,
Masui. The Japanese journal of anesthesiology,
L P Adam, and
E G Henderson
December 1994,
The Tokai journal of experimental and clinical medicine,
L P Adam, and
E G Henderson
January 1966,
Anesthesiology,
L P Adam, and
E G Henderson
January 1985,
Journal of neural transmission,
L P Adam, and
E G Henderson
August 1986,
European journal of pharmacology,
L P Adam, and
E G Henderson
July 1990,
Anesthesia and analgesia,
L P Adam, and
E G Henderson
January 1997,
Chest,
L P Adam, and
E G Henderson
October 1988,
Anesthesiology,
L P Adam, and
E G Henderson
May 1976,
Anesthesiology,
